CN Stock MarketDetailed Quotes

301301 Yili Chuanning Biotechnology

Watchlist
  • 12.35
  • +0.09+0.73%
Market Closed Dec 27 15:00 CST
27.51BMarket Cap19.98P/E (TTM)

Yili Chuanning Biotechnology Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
Total operating revenue
24.43%4.46B
32.20%3.2B
19.96%1.52B
26.24%4.82B
21.83%3.58B
21.84%2.42B
27.34%1.27B
18.21%3.82B
15.83%2.94B
19.52%1.98B
Operating revenue
24.43%4.46B
32.20%3.2B
19.96%1.52B
26.24%4.82B
21.83%3.58B
21.84%2.42B
27.34%1.27B
18.21%3.82B
15.83%2.94B
19.52%1.98B
Other operating revenue
----
10.06%180.27M
----
25.07%308.58M
----
27.61%163.8M
----
39.33%246.72M
----
--128.35M
Interest income
----
----
--0
----
----
----
--0
----
----
----
Commission income
----
----
--0
----
----
----
--0
----
----
----
Premiums earned
----
----
--0
----
----
----
--0
----
----
----
Total operating cost
13.95%3.15B
18.97%2.26B
5.55%1.1B
12.55%3.65B
11.77%2.77B
13.17%1.9B
18.70%1.04B
7.88%3.24B
7.41%2.48B
1.68B
Operating cost
13.97%2.86B
19.43%2.07B
6.54%998.93M
14.87%3.3B
18.97%2.51B
22.11%1.73B
28.21%937.61M
14.28%2.87B
10.02%2.11B
--1.42B
Operating tax surcharges
24.66%67.5M
24.55%46.43M
0.15%19.72M
21.31%66.65M
20.17%54.14M
24.89%37.28M
25.43%19.69M
37.32%54.94M
41.63%45.06M
--29.85M
Operating expense
33.78%19.57M
31.13%11.6M
-18.95%3.85M
96.96%22.57M
75.56%14.63M
37.99%8.84M
24.24%4.75M
17.05%11.46M
3.86%8.33M
--6.41M
Administration expense
12.92%120.91M
12.33%82.49M
13.95%46.79M
-0.66%143.13M
-45.84%107.07M
-49.39%73.44M
-47.51%41.06M
-37.53%144.08M
1.73%197.71M
--145.1M
Financial expense
-3.82%42.46M
-4.63%27.71M
-47.17%12.67M
-50.55%60.83M
-51.00%44.15M
-54.83%29.05M
-35.45%23.98M
-30.80%123.01M
-30.51%90.11M
--64.32M
-Interest expense (Financial expense)
-45.02%35.27M
-46.24%25.56M
-44.06%15.43M
-38.33%87.78M
-40.18%64.15M
-36.59%47.54M
-26.22%27.58M
-19.61%142.34M
-18.93%107.25M
--74.98M
-Interest Income (Financial expense)
55.38%-5.58M
53.53%-3.89M
67.01%-1.76M
-210.78%-16.18M
-221.62%-12.51M
-225.10%-8.38M
-361.64%-5.33M
11.17%-5.21M
-7.14%-3.89M
---2.58M
Research and development
12.82%44.07M
22.10%28.78M
21.11%16.68M
56.18%55.26M
47.89%39.06M
28.08%23.57M
29.36%13.77M
7.37%35.38M
5.25%26.41M
--18.4M
Credit Impairment Loss
1,182.16%2.33M
326.69%258.72K
493.65%750.54K
54.41%-6.5M
101.19%181.77K
100.39%60.64K
-118.87%-190.66K
-988.56%-14.26M
-188.34%-15.24M
---15.59M
Asset Impairment Loss
73.25%-8.45M
73.25%-8.45M
--0
-157.62%-42.65M
-148.09%-31.61M
-292.08%-31.61M
-359.97%-14.72M
-30.99%-16.56M
-25.21%-12.74M
---8.06M
Other net revenue
80.52%-7.06M
69.91%-11.68M
91.36%-1.35M
-58.72%-53.11M
-24.96%-36.22M
-73.43%-38.82M
-4,399.58%-15.63M
-966.33%-33.46M
-167.00%-28.99M
-22.39M
Fair value change income
135.44%644.5K
95.84%-224.6K
76.75%-519.93K
-1,938.52%-1.18M
56.61%-1.82M
-142.10%-5.39M
-208.63%-2.24M
-110.59%-58.08K
-1,120.05%-4.19M
---2.23M
Invest income
38.19%-7.16M
15.38%-6.31M
-325.42%-3.07M
-52.22%-13.55M
-1,825.75%-11.58M
-1,220.31%-7.46M
-156.02%-720.58K
-366.76%-8.9M
-126.19%-601.39K
--665.86K
Net open hedge income
----
----
----
----
----
----
----
----
----
--0
-Including: Investment income associates
-245.18%-365.35K
-69.19%-105.56K
-43.39%-38.89K
-105.78%-145.54K
-1,341.17%-105.85K
---62.39K
---27.12K
---70.73K
---7.34K
--0
Exchange income
----
----
----
----
----
----
----
----
----
--0
Asset deal income
--0
--0
----
--1.34M
--1.34M
--1.34M
----
----
--0
--0
Other revenue
-23.17%5.58M
-28.11%3.05M
-33.61%1.48M
49.45%9.45M
92.04%7.27M
50.02%4.24M
74.45%2.24M
68.56%6.32M
58.32%3.78M
--2.83M
Operating profit
66.69%1.29B
93.47%919.68M
98.48%423.23M
105.72%1.12B
79.07%776.74M
69.82%475.36M
77.89%213.24M
143.77%545.12M
96.22%433.77M
108.63%279.92M
Add:Non operating Income
462.05%1.07M
-61.40%67.37K
35.31%45.4K
5,650.76%1.98M
333.53%190.85K
582.04%174.54K
48.68%33.55K
-91.96%34.43K
-87.54%44.02K
--25.59K
Less:Non operating expense
114.25%17.87M
83.51%10.59M
-53.11%1.35M
-90.15%5.67M
-81.05%8.34M
323.11%5.77M
197.20%2.89M
-36.06%57.52M
220.81%44.01M
--1.36M
Total profit
66.27%1.28B
93.54%909.16M
100.55%421.92M
129.21%1.12B
97.17%768.59M
68.63%469.76M
76.91%210.39M
263.68%487.63M
87.68%389.81M
112.58%278.58M
Less:Income tax cost
57.24%201.97M
81.04%142.83M
98.33%69.29M
132.74%177.15M
123.30%128.44M
90.43%78.89M
90.66%34.94M
234.80%76.11M
60.67%57.52M
--41.43M
Net profit
68.08%1.08B
96.06%766.33M
100.99%352.63M
128.56%940.56M
92.65%640.15M
64.82%390.87M
74.41%175.45M
269.58%411.52M
93.31%332.29M
103.47%237.15M
Net profit from continuing operation
68.08%1.08B
96.06%766.33M
100.99%352.63M
128.56%940.56M
92.65%640.15M
64.82%390.87M
74.41%175.45M
269.58%411.52M
93.31%332.29M
--237.15M
Net income from discontinuing operating
----
--0
--0
----
----
----
--0
----
----
----
Less:Minority Profit
20,523.50%38.55K
21,386,700.00%23.53K
936,558.33%11.24K
250.67%997.72
72.73%-188.74
99.98%-0.11
99.41%-1.2
-258.09%-662.19
-199.34%-692.12
---499.91
Net profit of parent company owners
68.07%1.08B
96.05%766.3M
100.98%352.61M
128.56%940.56M
92.65%640.15M
64.82%390.87M
74.41%175.45M
269.58%411.52M
93.31%332.29M
103.47%237.15M
Earning per share
Basic earning per share
65.52%0.48
88.89%0.34
100.00%0.16
100.00%0.42
70.59%0.29
50.00%0.18
60.00%0.08
250.00%0.21
88.89%0.17
--0.12
Diluted earning per share
65.52%0.48
88.89%0.34
100.00%0.16
100.00%0.42
70.59%0.29
50.00%0.18
60.00%0.08
250.00%0.21
88.89%0.17
--0.12
Other composite income
0
0
Other composite income of parent company owners
----
----
--0
----
----
----
--0
----
----
----
Other composite income of minority owners
----
----
--0
----
----
----
--0
----
----
----
Total composite income
68.08%1.08B
96.06%766.33M
100.99%352.63M
128.56%940.56M
92.65%640.15M
64.82%390.87M
74.41%175.45M
269.58%411.52M
93.31%332.29M
237.15M
Total composite income of parent company owners
68.07%1.08B
96.05%766.3M
100.98%352.61M
128.56%940.56M
92.65%640.15M
64.82%390.87M
74.41%175.45M
269.58%411.52M
93.31%332.29M
--237.15M
Total composite income of minority owners
20,523.50%38.55K
21,386,700.00%23.53K
936,558.33%11.24K
250.67%997.72
72.73%-188.74
99.98%-0.11
99.41%-1.2
-258.09%-662.19
-199.34%-692.12
---499.91
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
Auditor
--
--
--
Tianjian Certified Public Accountants (Special General Partnership)
--
--
--
Tianjian Certified Public Accountants (Special General Partnership)
--
--
(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022
Total operating revenue 24.43%4.46B32.20%3.2B19.96%1.52B26.24%4.82B21.83%3.58B21.84%2.42B27.34%1.27B18.21%3.82B15.83%2.94B19.52%1.98B
Operating revenue 24.43%4.46B32.20%3.2B19.96%1.52B26.24%4.82B21.83%3.58B21.84%2.42B27.34%1.27B18.21%3.82B15.83%2.94B19.52%1.98B
Other operating revenue ----10.06%180.27M----25.07%308.58M----27.61%163.8M----39.33%246.72M------128.35M
Interest income ----------0--------------0------------
Commission income ----------0--------------0------------
Premiums earned ----------0--------------0------------
Total operating cost 13.95%3.15B18.97%2.26B5.55%1.1B12.55%3.65B11.77%2.77B13.17%1.9B18.70%1.04B7.88%3.24B7.41%2.48B1.68B
Operating cost 13.97%2.86B19.43%2.07B6.54%998.93M14.87%3.3B18.97%2.51B22.11%1.73B28.21%937.61M14.28%2.87B10.02%2.11B--1.42B
Operating tax surcharges 24.66%67.5M24.55%46.43M0.15%19.72M21.31%66.65M20.17%54.14M24.89%37.28M25.43%19.69M37.32%54.94M41.63%45.06M--29.85M
Operating expense 33.78%19.57M31.13%11.6M-18.95%3.85M96.96%22.57M75.56%14.63M37.99%8.84M24.24%4.75M17.05%11.46M3.86%8.33M--6.41M
Administration expense 12.92%120.91M12.33%82.49M13.95%46.79M-0.66%143.13M-45.84%107.07M-49.39%73.44M-47.51%41.06M-37.53%144.08M1.73%197.71M--145.1M
Financial expense -3.82%42.46M-4.63%27.71M-47.17%12.67M-50.55%60.83M-51.00%44.15M-54.83%29.05M-35.45%23.98M-30.80%123.01M-30.51%90.11M--64.32M
-Interest expense (Financial expense) -45.02%35.27M-46.24%25.56M-44.06%15.43M-38.33%87.78M-40.18%64.15M-36.59%47.54M-26.22%27.58M-19.61%142.34M-18.93%107.25M--74.98M
-Interest Income (Financial expense) 55.38%-5.58M53.53%-3.89M67.01%-1.76M-210.78%-16.18M-221.62%-12.51M-225.10%-8.38M-361.64%-5.33M11.17%-5.21M-7.14%-3.89M---2.58M
Research and development 12.82%44.07M22.10%28.78M21.11%16.68M56.18%55.26M47.89%39.06M28.08%23.57M29.36%13.77M7.37%35.38M5.25%26.41M--18.4M
Credit Impairment Loss 1,182.16%2.33M326.69%258.72K493.65%750.54K54.41%-6.5M101.19%181.77K100.39%60.64K-118.87%-190.66K-988.56%-14.26M-188.34%-15.24M---15.59M
Asset Impairment Loss 73.25%-8.45M73.25%-8.45M--0-157.62%-42.65M-148.09%-31.61M-292.08%-31.61M-359.97%-14.72M-30.99%-16.56M-25.21%-12.74M---8.06M
Other net revenue 80.52%-7.06M69.91%-11.68M91.36%-1.35M-58.72%-53.11M-24.96%-36.22M-73.43%-38.82M-4,399.58%-15.63M-966.33%-33.46M-167.00%-28.99M-22.39M
Fair value change income 135.44%644.5K95.84%-224.6K76.75%-519.93K-1,938.52%-1.18M56.61%-1.82M-142.10%-5.39M-208.63%-2.24M-110.59%-58.08K-1,120.05%-4.19M---2.23M
Invest income 38.19%-7.16M15.38%-6.31M-325.42%-3.07M-52.22%-13.55M-1,825.75%-11.58M-1,220.31%-7.46M-156.02%-720.58K-366.76%-8.9M-126.19%-601.39K--665.86K
Net open hedge income --------------------------------------0
-Including: Investment income associates -245.18%-365.35K-69.19%-105.56K-43.39%-38.89K-105.78%-145.54K-1,341.17%-105.85K---62.39K---27.12K---70.73K---7.34K--0
Exchange income --------------------------------------0
Asset deal income --0--0------1.34M--1.34M--1.34M----------0--0
Other revenue -23.17%5.58M-28.11%3.05M-33.61%1.48M49.45%9.45M92.04%7.27M50.02%4.24M74.45%2.24M68.56%6.32M58.32%3.78M--2.83M
Operating profit 66.69%1.29B93.47%919.68M98.48%423.23M105.72%1.12B79.07%776.74M69.82%475.36M77.89%213.24M143.77%545.12M96.22%433.77M108.63%279.92M
Add:Non operating Income 462.05%1.07M-61.40%67.37K35.31%45.4K5,650.76%1.98M333.53%190.85K582.04%174.54K48.68%33.55K-91.96%34.43K-87.54%44.02K--25.59K
Less:Non operating expense 114.25%17.87M83.51%10.59M-53.11%1.35M-90.15%5.67M-81.05%8.34M323.11%5.77M197.20%2.89M-36.06%57.52M220.81%44.01M--1.36M
Total profit 66.27%1.28B93.54%909.16M100.55%421.92M129.21%1.12B97.17%768.59M68.63%469.76M76.91%210.39M263.68%487.63M87.68%389.81M112.58%278.58M
Less:Income tax cost 57.24%201.97M81.04%142.83M98.33%69.29M132.74%177.15M123.30%128.44M90.43%78.89M90.66%34.94M234.80%76.11M60.67%57.52M--41.43M
Net profit 68.08%1.08B96.06%766.33M100.99%352.63M128.56%940.56M92.65%640.15M64.82%390.87M74.41%175.45M269.58%411.52M93.31%332.29M103.47%237.15M
Net profit from continuing operation 68.08%1.08B96.06%766.33M100.99%352.63M128.56%940.56M92.65%640.15M64.82%390.87M74.41%175.45M269.58%411.52M93.31%332.29M--237.15M
Net income from discontinuing operating ------0--0--------------0------------
Less:Minority Profit 20,523.50%38.55K21,386,700.00%23.53K936,558.33%11.24K250.67%997.7272.73%-188.7499.98%-0.1199.41%-1.2-258.09%-662.19-199.34%-692.12---499.91
Net profit of parent company owners 68.07%1.08B96.05%766.3M100.98%352.61M128.56%940.56M92.65%640.15M64.82%390.87M74.41%175.45M269.58%411.52M93.31%332.29M103.47%237.15M
Earning per share
Basic earning per share 65.52%0.4888.89%0.34100.00%0.16100.00%0.4270.59%0.2950.00%0.1860.00%0.08250.00%0.2188.89%0.17--0.12
Diluted earning per share 65.52%0.4888.89%0.34100.00%0.16100.00%0.4270.59%0.2950.00%0.1860.00%0.08250.00%0.2188.89%0.17--0.12
Other composite income 00
Other composite income of parent company owners ----------0--------------0------------
Other composite income of minority owners ----------0--------------0------------
Total composite income 68.08%1.08B96.06%766.33M100.99%352.63M128.56%940.56M92.65%640.15M64.82%390.87M74.41%175.45M269.58%411.52M93.31%332.29M237.15M
Total composite income of parent company owners 68.07%1.08B96.05%766.3M100.98%352.61M128.56%940.56M92.65%640.15M64.82%390.87M74.41%175.45M269.58%411.52M93.31%332.29M--237.15M
Total composite income of minority owners 20,523.50%38.55K21,386,700.00%23.53K936,558.33%11.24K250.67%997.7272.73%-188.7499.98%-0.1199.41%-1.2-258.09%-662.19-199.34%-692.12---499.91
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------Unqualified opinion------Unqualified opinion----
Auditor ------Tianjian Certified Public Accountants (Special General Partnership)------Tianjian Certified Public Accountants (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CN
Overall
Symbol
Price
% Chg

No Data

Investment Theme Biomedical
Biomedical
Intraday+0.69%
Western Development
Western Development
Intraday+0.60%